A detailed history of Cullen/Frost Bankers, Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Cullen/Frost Bankers, Inc. holds 18,233 shares of EW stock, worth $1.24 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
18,233
Previous 42,270 56.87%
Holding current value
$1.24 Million
Previous $3.9 Million 69.19%
% of portfolio
0.02%
Previous 0.06%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$59.7 - $93.78 $1.44 Million - $2.25 Million
-24,037 Reduced 56.87%
18,233 $1.2 Million
Q2 2024

Aug 05, 2024

SELL
$84.3 - $94.31 $10.8 Million - $12 Million
-127,534 Reduced 75.11%
42,270 $3.9 Million
Q1 2024

May 10, 2024

SELL
$72.54 - $95.56 $558,775 - $736,098
-7,703 Reduced 4.34%
169,804 $16.2 Million
Q4 2023

Feb 06, 2024

SELL
$61.71 - $77.76 $451,285 - $568,658
-7,313 Reduced 3.96%
177,507 $13.5 Million
Q3 2023

Nov 02, 2023

SELL
$69.28 - $93.38 $294,786 - $397,331
-4,255 Reduced 2.25%
184,820 $12.8 Million
Q2 2023

Aug 04, 2023

BUY
$81.41 - $94.33 $1.14 Million - $1.32 Million
14,015 Added 8.01%
189,075 $17.8 Million
Q1 2023

May 05, 2023

SELL
$74.26 - $84.51 $1.74 Million - $1.98 Million
-23,450 Reduced 11.81%
175,060 $14.5 Million
Q4 2022

Feb 13, 2023

BUY
$68.3 - $87.44 $2.78 Million - $3.57 Million
40,772 Added 25.85%
198,510 $14.8 Million
Q3 2022

Nov 07, 2022

BUY
$82.37 - $107.29 $415,968 - $541,814
5,050 Added 3.31%
157,738 $13 Million
Q2 2022

Aug 05, 2022

SELL
$86.5 - $128.27 $67,124 - $99,537
-776 Reduced 0.51%
152,688 $14.5 Million
Q1 2022

May 09, 2022

BUY
$101.96 - $128.34 $90,948 - $114,479
892 Added 0.58%
153,464 $18.1 Million
Q4 2021

Feb 07, 2022

SELL
$106.37 - $130.68 $541,210 - $664,899
-5,088 Reduced 3.23%
152,572 $19.8 Million
Q3 2021

Nov 04, 2021

SELL
$102.91 - $122.75 $751,757 - $896,688
-7,305 Reduced 4.43%
157,660 $17.8 Million
Q2 2021

Aug 05, 2021

SELL
$83.84 - $104.76 $1.32 Million - $1.65 Million
-15,776 Reduced 8.73%
164,965 $17.1 Million
Q1 2021

May 05, 2021

SELL
$78.68 - $90.67 $236,590 - $272,644
-3,007 Reduced 1.64%
180,741 $15.1 Million
Q4 2020

Feb 08, 2021

SELL
$71.69 - $91.23 $420,390 - $534,972
-5,864 Reduced 3.09%
183,748 $16.8 Million
Q3 2020

Nov 05, 2020

SELL
$67.19 - $87.44 $917,748 - $1.19 Million
-13,659 Reduced 6.72%
189,612 $15.1 Million
Q2 2020

Aug 05, 2020

BUY
$57.54 - $76.95 $7.65 Million - $10.2 Million
133,016 Added 189.33%
203,271 $14 Million
Q1 2020

May 01, 2020

SELL
$52.41 - $81.0 $74,841 - $115,668
-1,428 Reduced 1.99%
70,255 $13.3 Million
Q4 2019

Feb 06, 2020

SELL
$71.7 - $82.09 $73,994 - $84,716
-1,032 Reduced 1.42%
71,683 $16.7 Million
Q3 2019

Nov 01, 2019

SELL
$61.55 - $75.43 $169,878 - $208,186
-2,760 Reduced 3.66%
72,715 $16 Million
Q2 2019

Aug 01, 2019

SELL
$55.74 - $64.41 $15,272 - $17,648
-274 Reduced 0.36%
75,475 $13.9 Million
Q1 2019

Apr 30, 2019

SELL
$47.89 - $64.05 $117,905 - $157,691
-2,462 Reduced 3.15%
75,749 $14.5 Million
Q4 2018

Feb 06, 2019

SELL
$46.41 - $56.94 $2.88 Million - $3.53 Million
-62,031 Reduced 44.23%
78,211 $12 Million
Q3 2018

Oct 29, 2018

SELL
$45.7 - $58.03 $905,774 - $1.15 Million
-19,820 Reduced 12.38%
140,242 $24.4 Million
Q2 2018

Jul 27, 2018

SELL
$42.45 - $51.3 $692,868 - $837,318
-16,322 Reduced 9.25%
160,062 $23.3 Million
Q1 2018

May 11, 2018

BUY
$37.19 - $47.45 $1.6 Million - $2.04 Million
42,990 Added 32.23%
176,384 $24.6 Million
Q4 2017

Jan 31, 2018

BUY
$33.79 - $39.39 $245,518 - $286,207
7,266 Added 5.76%
133,394 $15 Million
Q3 2017

Nov 02, 2017

BUY
$36.29 - $38.83 $4.58 Million - $4.9 Million
126,128
126,128 $13.8 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Cullen/Frost Bankers, Inc. Portfolio

Follow Cullen/Frost Bankers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullen/Frost Bankers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cullen/Frost Bankers, Inc. with notifications on news.